The role of genetic variants in CYP2C8, LPIN1, PPARGC1A and PPARγ on the trough steady-state plasma concentrations of rosiglitazone and on glycosylated haemoglobin A1c in type 2 diabetes-Reference-Cited by-同舟云学术

The role of genetic variants in CYP2C8, LPIN1, PPARGC1A and PPARγ on the trough steady-state plasma concentrations of rosiglitazone and on glycosylated haemoglobin A1c in type 2 diabetes

Published:2013-04 Issue:4 Volume:23 Page:219-227
ISSN:1744-6872
Container-title:Pharmacogenetics and Genomics
language:en
Short-container-title:

Author:

Stage Tore B.,Christensen Mette M.H.,Feddersen Søren,Beck-Nielsen Henning,Brøsen Kim

Publisher

Ovid Technologies (Wolters Kluwer Health)

Subject

Genetics (clinical),Genetics,Molecular Biology,Molecular Medicine,General Pharmacology, Toxicology and Pharmaceutics

Reference44 articles.

1. Diabetes mellitus, fasting glucose, and risk of cause-specific death.;Seshasai;N Engl J Med,2011

2. Identification of high-affinity binding sites for the insulin sensitizer rosiglitazone (BRL-49653) in rodent and human adipocytes using a radioiodinated ligand for peroxisomal proliferator-activated receptor gamma.;Young;J Pharmacol Exp Ther,1998

3. Lipin, a lipodystrophy and obesity gene.;Phan;Cell Metab,2005

4. Lipin expression preceding peroxisome proliferator-activated receptor-gamma is critical for adipogenesis in vivo and in vitro.;Phan;J Biol Chem,2004

5. Lipin-1 phosphatidic phosphatase activity modulates phosphatidate levels to promote peroxisome proliferator-activated receptor gamma (PPARgamma) gene expression during adipogenesis.;Zhang;J Biol Chem,2012

Cited by 27 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Pharmacogenomics: The roles of genetic factors on treatment response and outcomes in diabetes;Internet of Things and Machine Learning for Type I and Type II Diabetes;2024

2. Selected musculoskeletal disorders in patients with thyroid dysfunction, diabetes, and obesity;Rheumatology;2023-08-31

3. Genetic polymorphisms of CYP2B6*6, CYP2C8*3 and CYP2D6*4 in vivax malaria patients from Brazilian Amazon;Brazilian Journal of Pharmaceutical Sciences;2023

4. Awareness of Genetic Polymorphism in Drug Metabolizing Enzymes and Transporters May Promote Personalized Type 2 Diabetes Management [Letter];Diabetes, Metabolic Syndrome and Obesity: Targets and Therapy;2022-02

5. Pharmacogenomic Studies of Current Antidiabetic Agents and Potential New Drug Targets for Precision Medicine of Diabetes;Diabetes Therapy;2020-09-15